Oracle is down big in 2026. Dan Ives says buy the dip

Wedbush initiated Oracle at outperform with a $225 price target, implying 27.6% upside from Thursday’s close. The firm argues Oracle is becoming a foundational AI infrastructure provider, citing $300 billion of contracted OpenAI demand over five years starting in 2027 and a partnership with Nvidia. Ives also said Oracle has already raised $30 billion of its planned $45-$50 billion capital raise, easing concerns about capex and negative free cash flow.

Analysis

Oracle is transitioning from a software multiple to an infrastructure balance-sheet story, and that matters because the market is still pricing it like a mature enterprise vendor rather than a contracted AI utility. The key second-order effect is that long-duration demand visibility can justify heavier upfront capex than the sell-side typically tolerates, especially when that spend is tied to named counterparties and financing is being pre-arranged. If the market starts to underwrite OCI as a constrained compute platform rather than a cyclical cloud player, the multiple can expand before reported cash flow fully inflects.

The more interesting winner may be Nvidia, not because of direct revenue capture alone, but because Oracle’s buildout effectively enlarges the addressable base of enterprise AI deployments that will be standardized on high-end accelerators and networking. That creates a flywheel for the full-stack ecosystem: more Oracle capacity means more inference and training workloads, which in turn increases demand for GPUs, interconnect, and power infrastructure. The losers are hyperscale skeptics and lower-tier cloud providers that lack the balance-sheet flexibility to pre-fund capacity against contracted demand.

The main risk is timing mismatch: equity investors want margin and free-cash-flow relief over the next 2-3 quarters, while the economics here may not show up cleanly until 2027 and beyond. If there is any slip in financing execution, customer concentration anxiety, or evidence that AI demand is more promotional than contractual, the stock could de-rate quickly because the market is implicitly granting Oracle credit for future utilization today. In that sense, the setup is bullish but brittle: good news likely drips through over months, while bad news can hit in days.

The consensus seems to be missing that the capital-raise itself is a signal of conviction, not just dilution risk. Investors are anchoring on negative free cash flow, but in infrastructure buildouts the inflection usually comes after financing is secured and capacity is visible, not after the cash flow statement looks pristine. If Oracle keeps converting financing into contracted capacity without execution gaps, the rerating could extend well beyond the initial 20-30% move.

Key Decisions for Investors

• Long ORCL on a 3-6 month horizon; target a rerating toward the mid-$200s if the market begins valuing contracted AI capacity instead of near-term FCF. Add on pullbacks tied to capex fear, but keep a tight stop if financing spreads widen materially.
• Pair trade: long ORCL / short a lower-quality cloud or software name with weaker balance-sheet flexibility and less AI-contracted visibility. The trade expresses relative winner selection: funded infrastructure versus narrative-only AI exposure.
• Buy NVDA on any Oracle-related weakness in the next 1-4 weeks; Oracle’s expansion is a second-order demand proxy for accelerators and networking, with upside if more enterprise AI deployments validate the full-stack thesis.
• For traders, consider ORCL call spreads 3-6 months out to capture rerating while limiting downside if the market continues to punish near-term FCF. The best entry is on post-rally consolidation, not on strength.
• If ORCL credit spreads widen or mandatory convert issuance becomes a recurring headline, reduce longs immediately. That would signal the market is shifting from 'funded growth' to 'balance-sheet strain,' which would compress the multiple fast.